IL81166A - Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium - Google Patents

Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium

Info

Publication number
IL81166A
IL81166A IL81166A IL8116687A IL81166A IL 81166 A IL81166 A IL 81166A IL 81166 A IL81166 A IL 81166A IL 8116687 A IL8116687 A IL 8116687A IL 81166 A IL81166 A IL 81166A
Authority
IL
Israel
Prior art keywords
compound
thiosulfate
pharmaceutically active
active combination
sulfite
Prior art date
Application number
IL81166A
Other languages
English (en)
Other versions
IL81166A0 (en
Original Assignee
Kaplan Ephraim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaplan Ephraim filed Critical Kaplan Ephraim
Priority to IL81166A priority Critical patent/IL81166A/xx
Publication of IL81166A0 publication Critical patent/IL81166A0/xx
Priority to US07/136,100 priority patent/US5045316A/en
Priority to AU83165/87A priority patent/AU594851B2/en
Priority to EP88300006A priority patent/EP0274404A1/en
Priority to ZA8841A priority patent/ZA8841B/xx
Priority to JP63000162A priority patent/JPS63239227A/ja
Publication of IL81166A publication Critical patent/IL81166A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL81166A 1987-01-05 1987-01-05 Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium IL81166A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
IL81166A IL81166A (en) 1987-01-05 1987-01-05 Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium
US07/136,100 US5045316A (en) 1987-01-05 1987-12-21 Pharmaceutical compositions and their use
AU83165/87A AU594851B2 (en) 1987-01-05 1987-12-31 Pharmaceutical compositions and their use
EP88300006A EP0274404A1 (en) 1987-01-05 1988-01-04 Pharmaceutical compositions and their use
ZA8841A ZA8841B (OSRAM) 1987-01-05 1988-01-05
JP63000162A JPS63239227A (ja) 1987-01-05 1988-01-05 薬剤組成物およびその使用

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL81166A IL81166A (en) 1987-01-05 1987-01-05 Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium

Publications (2)

Publication Number Publication Date
IL81166A0 IL81166A0 (en) 1987-08-31
IL81166A true IL81166A (en) 1990-03-19

Family

ID=11057417

Family Applications (1)

Application Number Title Priority Date Filing Date
IL81166A IL81166A (en) 1987-01-05 1987-01-05 Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium

Country Status (6)

Country Link
US (1) US5045316A (OSRAM)
EP (1) EP0274404A1 (OSRAM)
JP (1) JPS63239227A (OSRAM)
AU (1) AU594851B2 (OSRAM)
IL (1) IL81166A (OSRAM)
ZA (1) ZA8841B (OSRAM)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990012563A1 (en) * 1989-04-24 1990-11-01 Board Of Regents, The University Of Texas System Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
DE4336642C2 (de) * 1993-10-22 1995-08-10 Deutsches Rheuma Forschungszen Verwendung von Vanadiumverbindungen mit antiviraler Wirkung
US5639482A (en) * 1993-11-10 1997-06-17 Crary; Ely J. Composition for control and prevention of diabetic retinopathy
US5843481A (en) * 1994-01-18 1998-12-01 Mount Sinai Hospital Corporation Treatment of proliferative disorders, metastasaes, and drug resistant tumors with vanadate compounds and derivatives or analogues thereof
US5871779A (en) * 1994-01-18 1999-02-16 Mount Sinai Hospital Corporation Treatment of arthropathies with vanadate compounds or analogues thereof
US5962030A (en) 1997-03-07 1999-10-05 Akesis Pharmaceuticals, Inc. Dietary supplement and method of treatment for diabetic control
US6852760B1 (en) 1998-09-17 2005-02-08 Akesis Pharmaceuticals, Inc. Compositions and methods for treatment for glucose metabolism disorders
US6376549B1 (en) * 1998-09-17 2002-04-23 Akesis Pharmaceuticals, Inc. Metforimin-containing compositions for the treatment of diabetes
AU2736400A (en) * 1999-01-27 2000-08-18 University Of South Florida Inhibition of stat3 signal transduction for human cancer therapy
US20040052762A1 (en) * 2001-09-10 2004-03-18 Hua Yu Stat3 agonists and antagonists and therapeutic uses thereof
DE10135494A1 (de) * 2001-07-20 2003-11-06 Jobst Krauskopf Verwendung eines Lactatsalzes zur Behandlung und Prophylaxe der Athereosklerose
US7638122B2 (en) * 2003-03-07 2009-12-29 University Of South Florida Stat3 antagonists and their use as vaccines against cancer
DE102004025988A1 (de) * 2004-05-21 2005-12-08 Petersen, Jan, Dr. Verwendung von Vanadylverbindungen zur Behandlung von Tumorerkrankungen
MX2015009403A (es) 2013-01-28 2017-07-04 Nuevas Alternativas Naturales Thermafat S A P I De C V Composiciones para tratamiento sistemico de condiciones patologicas resultantes de estres oxidativo y/o desequilibrio redox.
US11289700B2 (en) 2016-06-28 2022-03-29 The Research Foundation For The State University Of New York KVOPO4 cathode for sodium ion batteries

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2135111A (en) * 1936-04-27 1938-11-01 Harry J Prebluda Vanadyl lactate and process of making it
US4464357A (en) * 1983-05-26 1984-08-07 T&R Chemicals, Inc. Treatment of epilepsy with bisulfite
US4462988A (en) * 1983-05-26 1984-07-31 T&R Chemicals, Inc. Treatment of arthritis with bisulfite
US4657764A (en) * 1983-05-26 1987-04-14 T & R Chemicals, Inc. Treatment of arthritis and arthritic conditions with sulfites and bisulfites
DE3419686A1 (de) * 1983-05-26 1984-11-29 T and R Chemicals, Inc., Clint, Tex. Verwendung einer zusammensetzung mit therapeutischer wirksamkeit
US4532131A (en) * 1984-05-08 1985-07-30 T And R Chemicals, Inc. Therapeutic compositions

Also Published As

Publication number Publication date
IL81166A0 (en) 1987-08-31
JPS63239227A (ja) 1988-10-05
AU8316587A (en) 1988-07-07
US5045316A (en) 1991-09-03
EP0274404A1 (en) 1988-07-13
ZA8841B (OSRAM) 1988-06-24
AU594851B2 (en) 1990-03-15

Similar Documents

Publication Publication Date Title
AU574851B2 (en) Oxygen and moisture barrier film
AU2424288A (en) Active and passive coordinated walking device
HUT46514A (en) Herbicides comprising aryl-triazolines and pr0cess for producing the active ingredients
DE3378917D1 (en) Hypocholesterolemically and/or hypotriglyceridemically active products
EP0210461A3 (en) Physiologically active polypeptide buf-3
IL81166A (en) Pharmaceutically active combination comprising an ionic vanadium compound and thiosulfate or sulfite compound and optionally selenium
AU4777585A (en) Active transconductance filter device
GB8323542D0 (en) Pharmaceutically active carbostyril derivatives
PT86000A (en) Pharmaceutically active compounds
KR890702330A (ko) 능동필터의 설비 및 제어
GR80724B (en) Pharmacologically active ketones and use
GB2200281B (en) Mask and strap
AU590421B2 (en) Certain 4-oxo-3-benzoylvalerolactones and thiolactones
PL253413A1 (en) Biologicaly active agent
DE3667011D1 (en) Herbicidally active epoxides
ZA876845B (en) Pharmacologically active compounds and use
NZ218721A (en) Imidazolinones and herbicidal compositions
PL265625A1 (en) Fungicidal specific and the method of manufacturing of active substance
PL256343A1 (en) Insecticide and/or acaricide
GB2135668B (en) Of4949, a physiologically active substance and derivatives thereof
ZA874979B (en) Pharmacologically active compounds and use
AU564680B2 (en) Herbicide containing methabenzthiazuron and pyridyloxyacetates
ZA891447B (en) Substituted imidazolinones and imidazolinethiones
NZ226246A (en) Phenoxyphenyl-substituted tetrazolinones and herbicides
GB8302006D0 (en) Pharmaceutically active nitrogen heterocycles and salts

Legal Events

Date Code Title Description
RH Patent void